SELLAS Life Sciences Group, Inc.
Pharmaceutical company · New York, United States · Nasdaq: SLS
SELLAS Life Sciences Group, Inc. is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker SLS. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2024.
SELLAS Life Sciences Group at a glance
What does SELLAS Life Sciences Group do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $18.4 million sold (2024).
Frequently asked questions about SELLAS Life Sciences Group
Where is SELLAS Life Sciences Group headquartered?
SELLAS Life Sciences Group, Inc. is headquartered in New York, United States.
What does SELLAS Life Sciences Group do?
SELLAS Life Sciences Group, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is SELLAS Life Sciences Group a public company?
Yes. SELLAS Life Sciences Group, Inc. trades on Nasdaq under the ticker SLS.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.